ATRASENTAN 0.75 MG TABLET

🧪 Composition

• Active Ingredient: Atrasentan
• Dosage Form: Oral Tablet
• Strength: 0.75 mg

✅ Uses

• Used to reduce proteinuria (excess protein in the urine) in adults with IgA nephropathy (IgAN) who are at risk of disease progression.
• Helps slow the progression of chronic kidney disease associated with IgAN.
• Supports preservation of kidney function when used alongside standard supportive therapy.
• Prescribed as part of a comprehensive kidney disease management plan.

💉 Dosage

Take Atrasentan 0.75 mg exactly as prescribed by your healthcare provider. The dosage and duration of treatment depend on your medical condition and response to therapy. Swallow the tablet whole with water, with or without food. Do not stop or adjust the dose without consulting your physician.

⚠️ Precautions

• Use only under the supervision of a qualified healthcare professional.
• Regular monitoring of kidney function, blood pressure, and fluid status may be required during treatment.
• Inform your doctor about any history of heart disease, liver disorders, fluid retention, or other medical conditions before starting therapy.
• Contact your healthcare provider if you experience swelling of the legs, sudden weight gain, shortness of breath, or other unusual symptoms.

📦 Storage

Store the tablets at room temperature in a cool, dry place away from moisture, heat, and direct sunlight. Keep the medicine in its original packaging and out of the reach of children.

⭐ Conclusion

Atrasentan 0.75 mg is a targeted treatment option for eligible adults with IgA nephropathy (IgAN). When used under regular medical supervision and alongside standard supportive care, it helps reduce proteinuria, supports kidney function, and may slow disease progression. Always follow your healthcare provider’s instructions for safe and effective treatment.